Skin Cancer
Online ISSN : 1884-3549
Print ISSN : 0915-3535
ISSN-L : 0915-3535
フェロンDAV療法を試みた転移性黒色腫の1例
栗原 聡武居 園子松橋 京子松井 健雄露木 重明
著者情報
ジャーナル フリー

1992 年 7 巻 3 号 p. 290-294

詳細
抄録

In this paper, we present a 27-year-old female of metastatic melanoma treated with interferon-β-DAV combination therapy, and in addition, the course of urine 5-S-cysteinyldopa excretion level was analyzed. Pretreatment urinary excretion level of 5-S-cysteinyldopa was 4, 118.7μg/day and declined immediately after dose. Every after dose, urinary excretion level increased and then decreased rapidly. This fluctuation continued throughout the treatment and the maximum urinary excretion level reached 8, 388μg/day. In comparison of previous reports, this case achieved long-term survival in spite of remarkable high urinary excretion level of 5-S-cysteinyldopa.

著者関連情報
© 日本皮膚悪性腫瘍学会
前の記事 次の記事
feedback
Top